Characterization of monoclonal antibodies against hepatitis C virus nonstructural protein 3: Different antigenic determinants from human B cells

Journal of Medical Virology

Volumn 57, Issue 4, 1999, Pages 345-350

  Ou Yang, Pu ^a   Chiang, Bor Luen ^a   Hwang, Lih Hwa ^a   Chen, Yi Guang ^a   Yang, Pei Ming ^a   Chi, Wei Kuang ^b   Chen, Pei Jer ^a   Chen, Ding Shinn ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatitis C virus; Monoclonal antibodies

Indexed keywords

B LYMPHOCYTE ANTIGEN; EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; VIRUS PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOBLOTTING; IMMUNOREGULATION; PEPTIDE MAPPING;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 84984567059     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199904)57:4<345::AID-JMV3>3.0.CO;2-N     Document Type: Article

References (29)

1. Aach RD, Stevens CE, Hollinger FB, Mosely JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. 1991. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assay. N Engl J Med 325:1325-1329.
2. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kuo G. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494-1500.
3. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H. 1993. Non-structural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 67:3835-3844.
4. Chen D-S, Kuo G, Sung J-L, Lai M-Y, Sheu J-C, Chen P-J, Yang P-M, Hsu H-M, Chang M-H, Chen C-J, Hahn L-C, Choo Q-L, Wang T-H, Houghton M. 1990. Hepatitis C virus infection in the area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 162:817-822.
5. Chen P-J, Lin M-H, Tai K-F, Liu P-C, Lin C-J, Chen D-S. 1992. The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5′ termini of viral genomic and antigenic RNA. Virology 188:102-113.
6. Chiang B-L, Yang P-M, Hwang L-H, Wang J-M, Kao S-F, Pan C-H, Chi W-K, Chen P-J, Chen D-S. 1998. Establishment and characterization of NS3-specific T cell clones from a patient with chronic hepatitis C. J Biomed Sci 5:290-296.
7. Chien DY, Choo Q-L, Tabrizi A, Kuo G, McFarland J, Berger K, Lee C, Shuster JR, Nguyen T, Moyer DL, Tong M, Furuta S, Omata M, Tegtmeimer G, Alter H, Schiff E, Jeffers LM, Houghton M, Kuo G. 1992. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polypeptide to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci USA 89:10011-10015.
8. Chisari FV. 1997. Cytotoxic T cells and viral hepatitis. J Clin Invest 99:1472-1477.
9. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
10. Claeys H, Volckaerts A, Mertens W, Liang Z, Fiten P, Opdenakker G. 1995. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus. J Med Virol 45:273-281.
11. Farci P, Alter HJ, Govindarajan S, Wong DC, Eagle R, Lesniewski RR. Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH. 1992. Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140.
12. Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, Mori C, Fuke I, Okayama H, Kamada T. 1992. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic disease with monoclonal antibodies to core, envelop and NS3 regions of the hepatitis C virus genome. Hepatology 16:306-311.
13. Hwang L-H, Yang P-M, Lai M-Y, Chiang B-L, Kao J-H, Wang J-T, Lee S-Y, Chian H-M, Chi W-K, Chu Y-D, Chen P-J, Chen D-S. 1996. Identification of dominant humoral antigenic determinants within the hepatitis C virus nonstructural protein 3. J Infect Dis 174: 173-176.
14. Katayama T, Kikuchi S, Tanaka Y, Saito I, Miyamura T, Choo Q-L, Houghton M, Kuo G. 1990. Blood screening for non-A, non-B hepatitis C virus antibody assay. Transfusion 30:374-376.
15. Koskinas J, McFarlane BM, Nouri-Aria KT, Tibbs CJ, Mizokami M, Donaldson PT, McFarlane IG, Williams R. 1994. Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology 107:1436-1442.
16. Mondelli MU, Cerino A, Boender P, Oudshoorn P, Middeldrop J, Fipaldini C, La Monica N, Habets W. 1994. Significance of the immune response to a major conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol 68:4829-4836.
17. Moradpour D, Wakita T, Tokushige K, Carlson RI, Krawczynski K, Wands JR. 1996. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. J Med Virol 48: 234-241.
18. Mosely JW, Aach RD, Hollinger FB, Stevens CE, Barbosa LH, Nemo GJ, Holland PV, Bancroft WH, Zimmerman HJ, Kuo G, Choo Q-L, Houghton M. 1990. Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA 263:77-78.
19. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. 1992. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 16:300-305.
20. Napoli J, Bishop GA, McGuiness PH, Painter DM, McCaughan GW. 1996. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759-765.
21. Nasoff MS, Zebedee SL, Inchauspe G, Prince AM. 1991. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci USA 88:5462-5466.
22. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, Fukuda S, Tsuda F, Mishiro S. 1992a. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 188: 331-341.
23. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. 1992b. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679.
24. Sallberg M, Zhang ZX, Chen M, Jin L, Birkett A, Peterson DL, Milich DR. 1996. Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein. J Gen Virol 77:2721-2728.
25. Santolini E, Migliaccio G, Monica N. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 68:3631-3641.
26. Siemoneit K, da Silva Cardoso M, Wolpl A, Koerner K, Subanek B. 1994. Isolation and epitope characterization of human monoclonal antibodies to hepatitis C virus core protein. Hybridoma 13:9-13.
27. Tomai L, Failla C, Santolini E, De Francesco R, La Monica N. 1993. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67:4017-4026.
28. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proc Natl Acad Sci USA 89:3468-3472.
29. Yang P-M, Hwang L-H, Lai M-Y, Huang W-L, Chu Y-D, Chi W-K, Chiang B-L, Kao J-H, Chen P-J, Chen D-S. 1995. Prominent proliferative response of peripheral blood mononuclear cells to a recombinant nonstructural (NS3) protein of hepatitis virus in patients with chronic hepatitis C. Clin Exp Immunol 101:272-277.